Biotechnology: Global Industry Guide

Biotechnology: Global Industry Guide is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Contains an executive summary and data on value, volume and segmentation

* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).

* Includes a five-year forecast of the industry

Highlights

The global biotechnology market grew by 8.1% in 2010 to reach a value of $249,969 million.

In 2015, the global biotechnology market is forecast to have a value of $398,236.3 million, an increase of 59.3% since 2010.

Medical/Healthcare is the largest segment of the global biotechnology market, accounting for 67.1% of the market's total value.

Americas accounts for 46.2% of the global biotechnology market value.

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2011 annual average exchange rates.
[Fade out the market survey infos]

TABLE OF CONTENTS
ABOUT DATAMONITOR 2
EXECUTIVE SUMMARY 3
INTRODUCTION 23
What is this report about? 23
Who is the target reader? 23
Definitions 23
GLOBAL BIOTECHNOLOGY 24
Market overview 24
Market value 25
Market segmentation I 26
Market segmentation II 27
Five forces analysis 28
Market forecasts 34
BIOTECHNOLOGY IN ASIA-PACIFIC 35
Market overview 35
Market value 36
Market segmentation I 37
Market segmentation II 38
Five forces analysis 39
Market forecasts 47
BIOTECHNOLOGY IN EUROPE 48
Market overview 48
Market value 49
Market segmentation I 50
Market segmentation II 51
Five forces analysis 52
Market forecasts 58
BIOTECHNOLOGY IN FRANCE 59
Market overview 59
Market value 60
Market segmentation I 61
Market segmentation II 62
Five forces analysis 63
Market forecasts 69
Macroeconomic indicators 70
BIOTECHNOLOGY IN GERMANY 72
Market overview 72
Market value 73
Market segmentation I 74
Market segmentation II 75
Five forces analysis 76
Market forecasts 82
Macroeconomic indicators 83
BIOTECHNOLOGY IN ITALY 85
Market overview 85
Market value 86
Market segmentation I 87
Market segmentation II 88
Five forces analysis 89
Market forecasts 95
Macroeconomic indicators 96
BIOTECHNOLOGY IN JAPAN 98
Market overview 98
Market value 99
Market segmentation I 100
Market segmentation II 101
Five forces analysis 102
Market forecasts 108
Macroeconomic indicators 109
BIOTECHNOLOGY IN BELGIUM 111
Market overview 111
Market value 112
Market segmentation I 113
Market segmentation II 114
Five forces analysis 115
Market forecasts 121
Macroeconomic indicators 122
BIOTECHNOLOGY IN CANADA 124
Market overview 124
Market value 125
Market segmentation I 126
Market segmentation II 127
Five forces analysis 128
Market forecasts 134
Macroeconomic indicators 135
BIOTECHNOLOGY IN CHINA 137
Market overview 137
Market value 138
Market segmentation I 139
Market segmentation II 140
Five forces analysis 141
Market forecasts 147
Macroeconomic indicators 148
BIOTECHNOLOGY IN THE NETHERLANDS 150
Market overview 150
Market value 151
Market segmentation I 152
Market segmentation II 153
Five forces analysis 154
Market forecasts 160
Macroeconomic indicators 161
BIOTECHNOLOGY IN SPAIN 163
Market overview 163
Market value 164
Market segmentation I 165
Market segmentation II 166
Five forces analysis 167
Market forecasts 173
Macroeconomic indicators 174
BIOTECHNOLOGY IN THE UNITED KINGDOM 176
Market overview 176
Market value 177
Market segmentation I 178
Market segmentation II 179
Five forces analysis 180
Market forecasts 186
Macroeconomic indicators 188
BIOTECHNOLOGY IN THE UNITED STATES 190
Market overview 190
Market value 191
Market segmentation I 192
Market segmentation II 193
Five forces analysis 194
Market forecasts 200
Macroeconomic indicators 202
COMPANY PROFILES 204
Astra Zeneca 204
Merck KGaA 208
Novartis AG 211
Pfizer Inc 215
APPENDIX 218
Data Research Methodology 218

LIST OF TABLES
Table 1: Global biotechnology market value: $ million, 2006–10 25
Table 2: Global biotechnology market segmentation I:% share, by value, 2010 26
Table 3: Global biotechnology market segmentation II: % share, by value, 2010 27
Table 4: Global biotechnology market value forecast: $ million, 2010–15 34
Table 5: Asia-Pacific biotechnology market value: $ million, 2006–10 36
Table 6: Asia-Pacific biotechnology market segmentation I:% share, by value, 2010 37
Table 7: Asia-Pacific biotechnology market segmentation II: % share, by value, 2010 38
Table 8: Asia-Pacific biotechnology market value forecast: $ million, 2010–15 47
Table 9: Europe biotechnology market value: $ million, 2006–10 49
Table 10: Europe biotechnology market segmentation I:% share, by value, 2010 50
Table 11: Europe biotechnology market segmentation II: % share, by value, 2010 51
Table 12: Europe biotechnology market value forecast: $ million, 2010–15 58
Table 13: France biotechnology market value: $ million, 2006–10 60
Table 14: France biotechnology market segmentation I:% share, by value, 2010 61
Table 15: France biotechnology market segmentation II: % share, by value, 2010 62
Table 16: France biotechnology market value forecast: $ million, 2010–15 69
Table 17: France size of population (million), 2006–10 70
Table 18: France gdp (constant 2000 prices, $ billion), 2006–10 70
Table 19: France gdp (current prices, $ billion), 2006–10 70
Table 20: France inflation, 2006–10 71
Table 21: France consumer price index (absolute), 2006–10 71
Table 22: France exchange rate, 2006–10 71
Table 23: Germany biotechnology market value: $ million, 2006–10 73
Table 24: Germany biotechnology market segmentation I:% share, by value, 2010 74
Table 25: Germany biotechnology market segmentation II: % share, by value, 2010 75
Table 26: Germany biotechnology market value forecast: $ million, 2010–15 82
Table 27: Germany size of population (million), 2006–10 83
Table 28: Germany gdp (constant 2000 prices, $ billion), 2006–10 83
Table 29: Germany gdp (current prices, $ billion), 2006–10 83
Table 30: Germany inflation, 2006–10 84
Table 31: Germany consumer price index (absolute), 2006–10 84
Table 32: Germany exchange rate, 2006–10 84
Table 33: Italy biotechnology market value: $ million, 2006–10 86
Table 34: Italy biotechnology market segmentation I:% share, by value, 2010 87
Table 35: Italy biotechnology market segmentation II: % share, by value, 2010 88
Table 36: Italy biotechnology market value forecast: $ million, 2010–15 95
Table 37: Italy size of population (million), 2006–10 96
Table 38: Italy gdp (constant 2000 prices, $ billion), 2006–10 96
Table 39: Italy gdp (current prices, $ billion), 2006–10 96
Table 40: Italy inflation, 2006–10 97
Table 41: Italy consumer price index (absolute), 2006–10 97
Table 42: Italy exchange rate, 2006–10 97
Table 43: Japan biotechnology market value: $ million, 2006–10 99
Table 44: Japan biotechnology market segmentation I:% share, by value, 2010 100
Table 45: Japan biotechnology market segmentation II: % share, by value, 2010 101
Table 46: Japan biotechnology market value forecast: $ million, 2010–15 108
Table 47: Japan size of population (million), 2006–10 109
Table 48: Japan gdp (constant 2000 prices, $ billion), 2006–10 109
Table 49: Japan gdp (current prices, $ billion), 2006–10 109
Table 50: Japan inflation, 2006–10 110
Table 51: Japan consumer price index (absolute), 2006–10 110
Table 52: Japan exchange rate, 2006–10 110
Table 53: Belgium biotechnology market value: $ million, 2006–10 112
Table 54: Belgium biotechnology market segmentation I:% share, by value, 2010 113
Table 55: Belgium biotechnology market segmentation II: % share, by value, 2010 114
Table 56: Belgium biotechnology market value forecast: $ million, 2010–15 121
Table 57: Belgium size of population (million), 2006–10 122
Table 58: Belgium gdp (constant 2000 prices, $ billion), 2006–10 122
Table 59: Belgium gdp (current prices, $ billion), 2006–10 122
Table 60: Belgium inflation, 2006–10 123
Table 61: Belgium consumer price index (absolute), 2006–10 123
Table 62: Belgium exchange rate, 2006–10 123
Table 63: Canada biotechnology market value: $ million, 2006–10 125
Table 64: Canada biotechnology market segmentation I:% share, by value, 2010 126
Table 65: Canada biotechnology market segmentation II: % share, by value, 2010 127
Table 66: Canada biotechnology market value forecast: $ million, 2010–15 134
Table 67: Canada size of population (million), 2006–10 135
Table 68: Canada gdp (constant 2000 prices, $ billion), 2006–10 135
Table 69: Canada gdp (current prices, $ billion), 2006–10 135
Table 70: Canada inflation, 2006–10 136
Table 71: Canada consumer price index (absolute), 2006–10 136
Table 72: Canada exchange rate, 2006–10 136
Table 73: China biotechnology market value: $ million, 2006–10 138
Table 74: China biotechnology market segmentation I:% share, by value, 2010 139
Table 75: China biotechnology market segmentation II: % share, by value, 2010 140
Table 76: China biotechnology market value forecast: $ million, 2010–15 147
Table 77: China size of population (million), 2006–10 148
Table 78: China gdp (constant 2000 prices, $ billion), 2006–10 148
Table 79: China gdp (current prices, $ billion), 2006–10 148
Table 80: China inflation, 2006–10 149
Table 81: China consumer price index (absolute), 2006–10 149
Table 82: China exchange rate, 2006–10 149
Table 83: Netherlands biotechnology market value: $ million, 2006–10 151
Table 84: Netherlands biotechnology market segmentation I:% share, by value, 2010 152
Table 85: Netherlands biotechnology market segmentation II: % share, by value, 2010 153
Table 86: Netherlands biotechnology market value forecast: $ million, 2010–15 160
Table 87: Netherlands size of population (million), 2006–10 161
Table 88: Netherlands gdp (constant 2000 prices, $ billion), 2006–10 161
Table 89: Netherlands gdp (current prices, $ billion), 2006–10 161
Table 90: Netherlands inflation, 2006–10 162
Table 91: Netherlands consumer price index (absolute), 2006–10 162
Table 92: Netherlands exchange rate, 2006–10 162
Table 93: Spain biotechnology market value: $ million, 2006–10 164
Table 94: Spain biotechnology market segmentation I:% share, by value, 2010 165
Table 95: Spain biotechnology market segmentation II: % share, by value, 2010 166
Table 96: Spain biotechnology market value forecast: $ million, 2010–15 173
Table 97: Spain size of population (million), 2006–10 174
Table 98: Spain gdp (constant 2000 prices, $ billion), 2006–10 174
Table 99: Spain gdp (current prices, $ billion), 2006–10 174
Table 100: Spain inflation, 2006–10 175
Table 101: Spain consumer price index (absolute), 2006–10 175
Table 102: Spain exchange rate, 2006–10 175
Table 103: United Kingdom biotechnology market value: $ million, 2006–10 177
Table 104: United Kingdom biotechnology market segmentation I:% share, by value, 2010 178
Table 105: United Kingdom biotechnology market segmentation II: % share, by value, 2010 179
Table 106: United Kingdom biotechnology market value forecast: $ million, 2010–15 186
Table 107: United Kingdom size of population (million), 2006–10 188
Table 108: United Kingdom gdp (constant 2000 prices, $ billion), 2006–10 188
Table 109: United Kingdom gdp (current prices, $ billion), 2006–10 188
Table 110: United Kingdom inflation, 2006–10 189
Table 111: United Kingdom consumer price index (absolute), 2006–10 189
Table 112: United Kingdom exchange rate, 2006–10 189
Table 113: United States biotechnology market value: $ million, 2006–10 191
Table 114: United States biotechnology market segmentation I:% share, by value, 2010 192
Table 115: United States biotechnology market segmentation II: % share, by value, 2010 193
Table 116: United States biotechnology market value forecast: $ million, 2010–15 200
Table 117: United States size of population (million), 2006–10 202
Table 118: United States gdp (constant 2000 prices, $ billion), 2006–10 202
Table 119: United States gdp (current prices, $ billion), 2006–10 202
Table 120: United States inflation, 2006–10 203
Table 121: United States consumer price index (absolute), 2006–10 203
Table 122: United States exchange rate, 2006–10 203
Table 123: Astra Zeneca: key facts 204
Table 124: Astra Zeneca: key financials ($) 206
Table 125: Astra Zeneca: key financial ratios 206
Table 126: Merck KGaA: key facts 208
Table 127: Merck KGaA: key financials ($) 209
Table 128: Merck KGaA: key financials (€) 209
Table 129: Merck KGaA: key financial ratios 209
Table 130: Novartis AG: key facts 211
Table 131: Novartis AG: key financials ($) 212
Table 132: Novartis AG: key financial ratios 213
Table 133: Pfizer Inc: key facts 215
Table 134: Pfizer Inc: key financials ($) 216
Table 135: Pfizer Inc: key financial ratios 216

LIST OF FIGURES
Figure 1: Global biotechnology market value: $ million, 2006–10 25
Figure 2: Global biotechnology market segmentation I:% share, by value, 2010 26
Figure 3: Global biotechnology market segmentation II: % share, by value, 2010 27
Figure 4: Forces driving competition in the global biotechnology market, 2010 28
Figure 5: Drivers of buyer power in the global biotechnology market, 2010 29
Figure 6: Drivers of supplier power in the global biotechnology market, 2010 30
Figure 7: Factors influencing the likelihood of new entrants in the global biotechnology market, 2010 31
Figure 8: Factors influencing the threat of substitutes in the global biotechnology market, 2010 32
Figure 9: Drivers of degree of rivalry in the global biotechnology market, 2010 33
Figure 10: Global biotechnology market value forecast: $ million, 2010–15 34
Figure 11: Asia-Pacific biotechnology market value: $ million, 2006–10 36
Figure 12: Asia-Pacific biotechnology market segmentation I:% share, by value, 2010 37
Figure 13: Asia-Pacific biotechnology market segmentation II: % share, by value, 2010 38
Figure 14: Forces driving competition in the biotechnology market in Asia-Pacific, 2010 39
Figure 15: Drivers of buyer power in the biotechnology market in Asia-Pacific, 2010 40
Figure 16: Drivers of supplier power in the biotechnology market in Asia-Pacific, 2010 42
Figure 17: Factors influencing the likelihood of new entrants in the biotechnology market in Asia-Pacific, 2010 43
Figure 18: Factors influencing the threat of substitutes in the biotechnology market in Asia-Pacific, 2010 45
Figure 19: Drivers of degree of rivalry in the biotechnology market in Asia-Pacific, 2010 46
Figure 20: Asia-Pacific biotechnology market value forecast: $ million, 2010–15 47
Figure 21: Europe biotechnology market value: $ million, 2006–10 49
Figure 22: Europe biotechnology market segmentation I:% share, by value, 2010 50
Figure 23: Europe biotechnology market segmentation II: % share, by value, 2010 51
Figure 24: Forces driving competition in the biotechnology market in Europe, 2010 52
Figure 25: Drivers of buyer power in the biotechnology market in Europe, 2010 53
Figure 26: Drivers of supplier power in the biotechnology market in Europe, 2010 54
Figure 27: Factors influencing the likelihood of new entrants in the biotechnology market in Europe, 2010 55
Figure 28: Factors influencing the threat of substitutes in the biotechnology market in Europe, 2010 56
Figure 29: Drivers of degree of rivalry in the biotechnology market in Europe, 2010 57
Figure 30: Europe biotechnology market value forecast: $ million, 2010–15 58
Figure 31: France biotechnology market value: $ million, 2006–10 60
Figure 32: France biotechnology market segmentation I:% share, by value, 2010 61
Figure 33: France biotechnology market segmentation II: % share, by value, 2010 62
Figure 34: Forces driving competition in the biotechnology market in France, 2010 63
Figure 35: Drivers of buyer power in the biotechnology market in France, 2010 64
Figure 36: Drivers of supplier power in the biotechnology market in France, 2010 65
Figure 37: Factors influencing the likelihood of new entrants in the biotechnology market in France, 2010 66
Figure 38: Factors influencing the threat of substitutes in the biotechnology market in France, 2010 67
Figure 39: Drivers of degree of rivalry in the biotechnology market in France, 2010 68
Figure 40: France biotechnology market value forecast: $ million, 2010–15 69
Figure 41: Germany biotechnology market value: $ million, 2006–10 73
Figure 42: Germany biotechnology market segmentation I:% share, by value, 2010 74
Figure 43: Germany biotechnology market segmentation II: % share, by value, 2010 75
Figure 44: Forces driving competition in the biotechnology market in Germany, 2010 76
Figure 45: Drivers of buyer power in the biotechnology market in Germany, 2010 77
Figure 46: Drivers of supplier power in the biotechnology market in Germany, 2010 78
Figure 47: Factors influencing the likelihood of new entrants in the biotechnology market in Germany, 2010 79
Figure 48: Factors influencing the threat of substitutes in the biotechnology market in Germany, 2010 80
Figure 49: Drivers of degree of rivalry in the biotechnology market in Germany, 2010 81
Figure 50: Germany biotechnology market value forecast: $ million, 2010–15 82
Figure 51: Italy biotechnology market value: $ million, 2006–10 86
Figure 52: Italy biotechnology market segmentation I:% share, by value, 2010 87
Figure 53: Italy biotechnology market segmentation II: % share, by value, 2010 88
Figure 54: Forces driving competition in the biotechnology market in Italy, 2010 89
Figure 55: Drivers of buyer power in the biotechnology market in Italy, 2010 90
Figure 56: Drivers of supplier power in the biotechnology market in Italy, 2010 91
Figure 57: Factors influencing the likelihood of new entrants in the biotechnology market in Italy, 2010 92
Figure 58: Factors influencing the threat of substitutes in the biotechnology market in Italy, 2010 93
Figure 59: Drivers of degree of rivalry in the biotechnology market in Italy, 2010 94
Figure 60: Italy biotechnology market value forecast: $ million, 2010–15 95
Figure 61: Japan biotechnology market value: $ million, 2006–10 99
Figure 62: Japan biotechnology market segmentation I:% share, by value, 2010 100
Figure 63: Japan biotechnology market segmentation II: % share, by value, 2010 101
Figure 64: Forces driving competition in the biotechnology market in Japan, 2010 102
Figure 65: Drivers of buyer power in the biotechnology market in Japan, 2010 103
Figure 66: Drivers of supplier power in the biotechnology market in Japan, 2010 104
Figure 67: Factors influencing the likelihood of new entrants in the biotechnology market in Japan, 2010 105
Figure 68: Factors influencing the threat of substitutes in the biotechnology market in Japan, 2010 106
Figure 69: Drivers of degree of rivalry in the biotechnology market in Japan, 2010 107
Figure 70: Japan biotechnology market value forecast: $ million, 2010–15 108
Figure 71: Belgium biotechnology market value: $ million, 2006–10 112
Figure 72: Belgium biotechnology market segmentation I:% share, by value, 2010 113
Figure 73: Belgium biotechnology market segmentation II: % share, by value, 2010 114
Figure 74: Forces driving competition in the biotechnology market in Belgium, 2010 115
Figure 75: Drivers of buyer power in the biotechnology market in Belgium, 2010 116
Figure 76: Drivers of supplier power in the biotechnology market in Belgium, 2010 117
Figure 77: Factors influencing the likelihood of new entrants in the biotechnology market in Belgium, 2010 118
Figure 78: Factors influencing the threat of substitutes in the biotechnology market in Belgium, 2010 119
Figure 79: Drivers of degree of rivalry in the biotechnology market in Belgium, 2010 120
Figure 80: Belgium biotechnology market value forecast: $ million, 2010–15 121
Figure 81: Canada biotechnology market value: $ million, 2006–10 125
Figure 82: Canada biotechnology market segmentation I:% share, by value, 2010 126
Figure 83: Canada biotechnology market segmentation II: % share, by value, 2010 127
Figure 84: Forces driving competition in the biotechnology market in Canada, 2010 128
Figure 85: Drivers of buyer power in the biotechnology market in Canada, 2010 129
Figure 86: Drivers of supplier power in the biotechnology market in Canada, 2010 130
Figure 87: Factors influencing the likelihood of new entrants in the biotechnology market in Canada, 2010 131
Figure 88: Factors influencing the threat of substitutes in the biotechnology market in Canada, 2010 132
Figure 89: Drivers of degree of rivalry in the biotechnology market in Canada, 2010 133
Figure 90: Canada biotechnology market value forecast: $ million, 2010–15 134
Figure 91: China biotechnology market value: $ million, 2006–10 138
Figure 92: China biotechnology market segmentation I:% share, by value, 2010 139
Figure 93: China biotechnology market segmentation II: % share, by value, 2010 140
Figure 94: Forces driving competition in the biotechnology market in China, 2010 141
Figure 95: Drivers of buyer power in the biotechnology market in China, 2010 142
Figure 96: Drivers of supplier power in the biotechnology market in China, 2010 143
Figure 97: Factors influencing the likelihood of new entrants in the biotechnology market in China, 2010 144
Figure 98: Factors influencing the threat of substitutes in the biotechnology market in China, 2010 145
Figure 99: Drivers of degree of rivalry in the biotechnology market in China, 2010 146
Figure 100: China biotechnology market value forecast: $ million, 2010–15 147
Figure 101: Netherlands biotechnology market value: $ million, 2006–10 151
Figure 102: Netherlands biotechnology market segmentation I:% share, by value, 2010 152
Figure 103: Netherlands biotechnology market segmentation II: % share, by value, 2010 153
Figure 104: Forces driving competition in the biotechnology market in the Netherlands, 2010 154
Figure 105: Drivers of buyer power in the biotechnology market in the Netherlands, 2010 155
Figure 106: Drivers of supplier power in the biotechnology market in the Netherlands, 2010 156
Figure 107: Factors influencing the likelihood of new entrants in the biotechnology market in the Netherlands, 2010 157
Figure 108: Factors influencing the threat of substitutes in the biotechnology market in the Netherlands, 2010 158
Figure 109: Drivers of degree of rivalry in the biotechnology market in the Netherlands, 2010 159
Figure 110: Netherlands biotechnology market value forecast: $ million, 2010–15 160
Figure 111: Spain biotechnology market value: $ million, 2006–10 164
Figure 112: Spain biotechnology market segmentation I:% share, by value, 2010 165
Figure 113: Spain biotechnology market segmentation II: % share, by value, 2010 166
Figure 114: Forces driving competition in the biotechnology market in Spain, 2010 167
Figure 115: Drivers of buyer power in the biotechnology market in Spain, 2010 168
Figure 116: Drivers of supplier power in the biotechnology market in Spain, 2010 169
Figure 117: Factors influencing the likelihood of new entrants in the biotechnology market in Spain, 2010 170
Figure 118: Factors influencing the threat of substitutes in the biotechnology market in Spain, 2010 171
Figure 119: Drivers of degree of rivalry in the biotechnology market in Spain, 2010 172
Figure 120: Spain biotechnology market value forecast: $ million, 2010–15 173
Figure 121: United Kingdom biotechnology market value: $ million, 2006–10 177
Figure 122: United Kingdom biotechnology market segmentation I:% share, by value, 2010 178
Figure 123: United Kingdom biotechnology market segmentation II: % share, by value, 2010 179
Figure 124: Forces driving competition in the biotechnology market in the United Kingdom, 2010 180
Figure 125: Drivers of buyer power in the biotechnology market in the United Kingdom, 2010 181
Figure 126: Drivers of supplier power in the biotechnology market in the United Kingdom, 2010 182
Figure 127: Factors influencing the likelihood of new entrants in the biotechnology market in the United Kingdom, 2010 183
Figure 128: Factors influencing the threat of substitutes in the biotechnology market in the United Kingdom, 2010 184
Figure 129: Drivers of degree of rivalry in the biotechnology market in the United Kingdom, 2010 185
Figure 130: United Kingdom biotechnology market value forecast: $ million, 2010–15 187
Figure 131: United States biotechnology market value: $ million, 2006–10 191
Figure 132: United States biotechnology market segmentation I:% share, by value, 2010 192
Figure 133: United States biotechnology market segmentation II: % share, by value, 2010 193
Figure 134: Forces driving competition in the biotechnology market in the United States, 2010 194
Figure 135: Drivers of buyer power in the biotechnology market in the United States, 2010 195
Figure 136: Drivers of supplier power in the biotechnology market in the United States, 2010 196
Figure 137: Factors influencing the likelihood of new entrants in the biotechnology market in the United States, 2010 197
Figure 138: Factors influencing the threat of substitutes in the biotechnology market in the United States, 2010 198
Figure 139: Drivers of degree of rivalry in the biotechnology market in the United States, 2010 199
Figure 140: United States biotechnology market value forecast: $ million, 2010–15 201
Figure 141: Astra Zeneca: revenues & profitability 207
Figure 142: Astra Zeneca: assets & liabilities 207
Figure 143: Merck KGaA: revenues & profitability 210
Figure 144: Merck KGaA: assets & liabilities 210
Figure 145: Novartis AG: revenues & profitability 213
Figure 146: Novartis AG: assets & liabilities 214
Figure 147: Pfizer Inc: revenues & profitability 217
Figure 148: Pfizer Inc: assets & liabilities 217


[Fade out table of contents]